Posted on 01/15/2025 11:02:22 AM PST by ransomnote
Justus R. Hope discusses the potential of repurposed drugs, such as ivermectin and fenbendazole, in treating terminal cancers by targeting the metabolic drivers of cancer.
The Metabolic Theory of Cancer, described by Dr. Pierre Kory, states that cancer uses sugar and glutamine as fuel and that cancer cells have defective mitochondria and cannot metabolise ketone bodies.
Dr. Thomas Seyfried recommends starving cancer cells by restricting sugar and glutamine and feeding the body with ketones produced through fat consumption or fasting.
Supplements like green tea, curcumin and vitamins can be added to target cancer stem cells, and repurposed drugs like doxycycline and metformin have shown anti-cancer effects.
A low-seed-oil ketogenic diet is recommended, and therapeutic ketosis can act synergistically with conventional cancer treatments to enhance cancer management.
Fasting, exercise and vitamins like vitamin C and D have been identified as effective interventions in cancer treatment and prevention, with fasting being a potent stimulator of autophagy and P53 tumour suppressor function.
When Ivermectin and Fenbendazole Aren’t Enough
Justus R. Hope, who self-describes as a physician, writer and human rights advocate, publishes articles on a Substack page about repurposing life-saving generic drugs, among others.
Over the past few weeks, he/she has been publishing articles reviewing summaries artificial intelligence has generated in response to queries about ivermectin and fenbendazole for treating cancer and, when those are not enough, other treatments for terminal cancer.
The following are the articles in the series so far, beginning with an article about ivermectin and fenbendazole. Unfortunately, the bulk of the articles are behind a paywall. We have based our article on what is free to read in Justus R. Hope’s articles.
- AI Supports Ivermectin & Fenbendazole for Terminal Cancer
- When Ivermectin & Fenbendazole Aren’t Enough – Part 1
- When Ivermectin & Fenbendazole Aren’t Enough – Part 2
- When Ivermectin & Fenbendazole Aren’t Enough – Part 3
Fenbendazole is a broad-spectrum benzimidazole anthelmintic used to treat various gastrointestinal parasites in animals such as dogs, cats, horses, cattle and other species. It has gained interest in human medicine for its potential anticancer effects. Studies have shown that it can inhibit glycolysis, down-regulate glucose uptake, induce oxidative stress and enhance apoptosis in cancer cells. However, fenbendazole is not currently approved for use in humans by major regulatory bodies such as the US Food and Drug Administration (“FDA”) or the European Medicines Agency (“EMA”).
Read more: Fenbendazole, ScienceDirect
Article continues at link: https://expose-news.com/2025/01/14/when-ivermectin-and-fenbendazole-arent-enough/
bump
PING
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.